Invention Grant
- Patent Title: Methods of treatment using single doses of oritavancin
- Patent Title (中): 使用单剂量的奥利万星治疗方法
-
Application No.: US13060811Application Date: 2009-08-29
-
Publication No.: US08420592B2Publication Date: 2013-04-16
- Inventor: Dario Lehoux , Thomas R. Parr , Gregory Moeck , Pierre Etienne
- Applicant: Dario Lehoux , Thomas R. Parr , Gregory Moeck , Pierre Etienne
- Applicant Address: US NJ Parsippany
- Assignee: The Medicines Company
- Current Assignee: The Medicines Company
- Current Assignee Address: US NJ Parsippany
- Agency: Roylance, Abrams, Berdo & Goodman LLP
- International Application: PCT/US2009/055466 WO 20090829
- International Announcement: WO2010/025438 WO 20100304
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/04

Abstract:
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against a wide range of bacteria. Methods for the treatment, prophylaxis and prevention of bacterial infection and disease in animals, including humans, using a single dose of oritavancin over the course of therapy, are described.
Public/Granted literature
- US20110201546A1 METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN Public/Granted day:2011-08-18
Information query
IPC分类: